Introduction Hypospadias is a multifactorial malformation. Among previously described genes, the MAMLD1 has recently been identified in association with the development of hypospadias. So far, there are no studies in Latin America addressing this gene. The aim of this paper is to describe the presence of variants in exon 3 of the MAMLD1 in our population. Materials and Methods Using the Bio-Repository's database of the Human Genetics Institute, we identified 51 patients between 2008 and 2012 with varying degrees of isolated hypospadias. Exon 3 was sequenced looking for polymorphisms. These were assessed with in silico prediction algorithms to describe the effect of these changes on the function and structure of the protein.
Introduction Hypospadias is a multifactorial malformation. Among previously described genes, the MAMLD1 has recently been identified in association with the development of hypospadias. So far, there are no studies in Latin America addressing this gene. The aim of this paper is to describe the presence of variants in exon 3 of the MAMLD1 in our population. Materials and Methods Using the Bio-Repository's database of the Human Genetics Institute, we identified 51 patients between 2008 and 2012 with varying degrees of isolated hypospadias. Exon 3 was sequenced looking for polymorphisms. These were assessed with in silico prediction algorithms to describe the effect of these changes on the function and structure of the protein.
Results Four patients with 3 variants were identified. The p.S364P variant has not been previously described and has a deleterious effect. The other two, rs41313406 and rs61740566, have been previously described and are not considered variations with harmful effect on the protein function. The genotype-phenotype correlation varies in severity between the variables described. Conclusions For the first time a Latin American population is molecularly analyzed. The p. S364P variation has never been described before. Variations with different degrees of hypospadias are described.
Introduction
Hypospadias are considered a multifactorial disease given the interaction between molecular events and the environment. Molecular mechanisms are complex. To date, there are around 26 genes associated with the development of hypospadias. Recently, the MAMLD1 gene (̀Mastermind like domain containing protein 1'') association with hypospadias was identified. Given the complexity of the functions and interactions of MAMLD1 and processes yet to characterize as mentioned above, it is necessary to continue further studies on this gene. The purpose of this work is to make a description of variants in exon 3 of the gene MAMLD1 in Colombian patients affected with hypospadias.
Material and Methods

Population characteristics
During the period from January 2008 to October 2012, patients with isolated hypospadias were recruited. All types of clinical severity were included using Duckett's classification. Patients were selected from the DNA Bank of urological congenital malformations of the Institute of Human Genetics at the Pontificia Universidad Javeriana. Excluded cases were all syndromic hypospadias registered in the DNA Bank. All recruited cases were captured when surgery was scheduled to correct the congenital defect. All cases had a signed consent by the parents or legal representatives before being included in the study. Once patients were admitted to the study, a questionnaire was filled. The pool of demographic information included data from the patient and his parents, description of the malformation and diagnostic methods, prenatal history and detailed technical information about the surgical procedure. At the time of venipuncture during anesthetic induction, the blood sample was taken from a peripheral vein (3-5 mL) in tubes with anticoagulants. Subsequent extraction of DNA was made. Storage of samples was at À20°C. DNA extraction was performed using the method of salting-out with the Promega Wizard ® kit.
Extracted DNA was evaluated with spectrophotometry to determine the concentration and absorbance between 260 and 280 nanometers (GeneQuant Amersham Biosienciens ® ).
Sample and data processing
Once DNA was extracted, PCR for exon 3 of the MAMLD1 gene was done. This exon was divided into three fragments through the design of primers with the program Primer3 ® .
Amplification according to standardized protocols in the laboratory of Molecular Biology and Genetics at the Institute of Human Genetics at the Pontificia Universidad Javeriana was made using a thermal cycler from BIO-RAD ® iCycler.
Agarose gels were used stained with 1% ethidium bromide and visualized using UV light to reveal the size of the fragments.
Subsequently purification was performed using Results were analyzed according to the classification of the degree of the hypospadias. A population analysis was grados de hipospadias aislado. A estos se les realizó la secuenciación del exón 3. Los polimorfismos identificados fueron evaluados con algoritmos de predicción in silico para evaluar el efecto de estos cambios sobre la función y estructura de la proteína. Resultados Se encontraron 4 pacientes con 3 variantes. La variante p.S364P no ha sido descrita previamente y tiene un efecto deletéreo. Las otras 2, rs41313406 y rs61740566, han sido descritas previamente y no se consideran variaciones con potencial de efecto deletéreo sobre la función de la proteína. La correlación fenotipo-genotipo varía en severidad entre las variables descritas. Conclusiones Por primera vez se analiza molecularmente una población latinoamericana, encontrando la variante p.S364P no descrita previamente, y 2 variantes ya descritas previamente. 
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Results
During the study period 67 cases were collected. This corresponds to 34% of the total number of individuals included in the Bank. Of these, 51 samples for analysis were processed. Average age at the time of surgery was 5 years (AE4 years). The 50.9% of the cases came from Cundinamarca and the remaining from different departments of the country. According to the classification of Duckett, the most frequently operated degree was scrotal (35.29%), followed by penile hypospadias (25.49%). Sequencing analysis identified 3 changes in exon 3 of the MAMLD1 gene in 4 out of 51 analyzed individuals (►Table 1 and ►Fig. 1). Two changes were identified in patient number 21. The first identified change was p.S364P. This variant has not been previously described. There is only information of two cases of this variant in the latino population in the Exome Aggregation Consortium database. A frequency of 0.0002148 in latinos and a MAF ¼ 2.291e À 05 has been described. To assess the potential impacts of this variant in the protein, a damaging impact in 3 out of 5 algorithms was identified (►Table 1). The second change is the same as the one identified in patient number 130. In patient number 14 the variant p.P334S (rs41313406) was identified. According to prediction bioinformatic algorithms, this change has a potential impact on the function of the protein (►Table 1). This same variant was identified in patient number 64. The third change, p.V432A (rs61740566), present in patients number 21 and number 130, was identified as benign in 5 of the 6 algorithms. This change has been previously described (►Table 1). Allele frequency analysis showed that the population is in balance for each variant according to Hardy-Weinberg model (p ¼ 1.000). The SNP rs41313406 presented genotype frequencies for our study of CC (0. 
Discussion
This is the first study in our population and in Latin America that analyzes the presence of variations in the MAMLD1 gene. Three nucleotide changes were found in four of the 51 analyzed patients (►Table 1). The p.S364P change has not been reported previously. As with other variants of the MAMLD1 associated with hypospadias, the correlation of the genotype-phenotype changes from patient to patient.
7,8
Analysis in silico of this change showed a deleterious effect on negative effect on the protein. Interestingly, cases reported by other authors, and ours have the same phenotype of proximal hypospadias.
On the other hand, the SNP rs61740566 found in two of the 51 patients with isolated hypospadias, has no effect on the protein. Our results are consistent with other authors who have found it even in healthy controls.
9,10 The phenotype of our two individuals with the variant is distal hypospadias, compared with those reported by Kalfa et al. that had proximal hypospadias.
11,12
Our results as well as other authors, demonstrate that the phenotype varies in different degrees of severity of the hypospadias, with the variations of the MAMLD1.
We acknowledge that the majority of cases are proximal due to do the fact that our hospital is a reference center. We believe the average age of surgery is influenced by the administrative difficulties in our health system, that makes it harder for patients to consult a specialist. Nonetheless this limitations, they do not affect the results of our study.
Conclusions
For the first time in our country and our region, we assess on a molecular level patients with isolated hypospadias, looking for changes in the MAMLD1 gene. This new mutation gives more information about this recently described gene and the development of hypospadias. The variability of the phenotype in patients with the same genotype predicts a complex pathophysiology of the MAMLD1 gene. Future studies must focus on the co-expression with other genes and possible epigenetic and environmental factors associated with genetic variants in patients with hypospadias.
Ethical Responsibilities
Protection of people and animals
